Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederstatnews.com
STAT
Get the latest updates from STAT directly as they happen.
Follow now 229 followers
Latest posts
Last updated about 1 hour ago
STAT investigates the epidemic killing 178,000 Americans a year
about 1 hour ago
Dear Readers I want to bring your attention to “The Deadliest Drug,”...
STAT+: CDC plans to transfer monkeys to nonprofit’s sanctuary as it seeks to reduce animal testing
about 3 hours ago
As part of efforts to phase out the use of monkeys in...
STAT+: The hunt for FDA’s next leader
about 3 hours ago
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about...
STAT+: MIT says research has fallen 10 percent, and grad student enrollment is down
about 3 hours ago
MIT President Sally Kornbluth said Thursday that the school’s research enterprise has...
STAT+: BeOne wins FDA approval in lymphoma race
about 6 hours ago
Want to stay on top of the science and politics driving biotech...
STAT+: Why big digital health players are missing from Medicare’s chronic care experiment
about 6 hours ago
You’re reading the web edition of STAT’s Health Tech newsletter, our guide...
STAT+: Pharmalittle: We’re reading about upbeat results for a Duchenne drug, Takeda layoffs, and much more
about 6 hours ago
Rise and shine, everyone, another busy day is on the way. And...
STAT+: Three years of declining overdose deaths begets cautious optimism and some concerns
about 8 hours ago
Get your daily dose of health and medicine every weekday with STAT’s...
STAT+: Biogen’s tau-targeting Alzheimer’s drug posts mixed results in mid-stage study
about 9 hours ago
Biogen reported mixed results Thursday from a mid-stage clinical trial investigating a...
STAT+: Regenxbio says Duchenne gene therapy succeeded in clinical trial, paving way for FDA submission
about 9 hours ago
Regenxbio said Thursday that its experimental gene therapy for Duchenne muscular dystrophy...
STAT+: CREATE Medicines, a biotech company developing CAR-T therapies, raises $122 million
about 9 hours ago
CREATE Medicines has a new name, an expanded pipeline, and now fresh...
STAT+: ‘No drama’ Diamantas should serve biotech well as acting FDA chief
about 9 hours ago
This is the online version of Adam’s Biotech Scorecard, a subscriber-only newsletter...